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ABSTRACT

Extibacter muris is a newly described mouse gut bacterium which metabolizes cholic acid (CA) to
deoxycholic acid (DCA) via 7α-dehydroxylation. Although bile acids influence metabolic and
inflammatory responses, few in vivo models exist for studying their metabolism and impact on
the host. Mice were colonized from birth with the simplified community Oligo-MM12 with or
without E. muris. As the metabolism of bile acids is known to affect lipid homeostasis, mice were
fed either a low- or high-fat diet for eight weeks before sampling and analyses targeting the gut and
liver. Multiple Oligo-MM12 strains were capable of deconjugating primary bile acids in vitro. E. muris
produced DCA from CA either as pure compound or in mouse bile. This production was inducible
by CA in vitro. Ursodeoxycholic, chenodeoxycholic, and β-muricholic acid were not metabolized
under the conditions tested. All gnotobiotic mice were stably colonized with E. muris, which
showed higher relative abundances after HF diet feeding. The presence of E. muris had minor, dietdependent effects on Oligo-MM12 communities. The secondary bile acids DCA and surprisingly LCA
and their taurine conjugates were detected exclusively in E. muris-colonized mice. E. muris colonization did not influence body weight, white adipose tissue mass, liver histopathology, hepatic
aspartate aminotransferase, or blood levels of cholesterol, insulin, and paralytic peptide (PP).
However, proteomics revealed shifts in hepatic pathways involved in amino acid, glucose, lipid,
energy, and drug metabolism in E. muris-colonized mice. Liver fatty acid composition was substantially altered by dietary fat but not by E. muris.In summary, E. muris stably colonized the gut of
mice harboring a simplified community and produced secondary bile acids, which affected proteomes in the liver. This new gnotobiotic mouse model can now be used to study the pathophysiological role of secondary bile acids in vivo.

Introduction

The gut microbiome, i.e. the community of
microbes residing in the intestine of humans and
other animals, plays an important role in host
health and the development of chronic diseases
such as metabolic disorders and liver cancer.1,2 In
contrast to the high number of studies focusing on
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shifts in fecal microbiomes under disease conditions, there is a limited amount of data on how
microbe-host interactions function, with few models available to study those interactions.3,4 Hence,
there is an urgent need for experimental studies
dissecting mediators of microbe-host interactions,
such as the myriad of metabolites produced by
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microbes. Bile acids are among the best examples of
such metabolites: they are synthesized in the liver in
the form of conjugated primary bile acids that, once
secreted in the small intestine, can be metabolized
by gut bacteria. This bacterial metabolism substantially impacts the bioavailability and bioactivities of
bile acids, which are known to regulate inﬂammatory and metabolic responses.5 Thus, it is essential
to study the bacteria capable of converting bile
acids.
The enzymatic reactions involved in bile acid
metabolism by gut bacteria start with deconjugation (the removal of amino acid residues bound to
primary bile acids) via bile salt hydrolase (BSH)
activity.6 Free primary bile acids can then be metabolized further via removal of hydroxyl groups
(dehydroxylation), oxidation (dehydrogenation),
or epimerization.7 Whereas BSH activity is
known to be carried out by a variety of phylogenetically diverse taxa,8 including species able to
colonize the small intestine, the other reactions
are thought to be restricted to bile acids escaping
re-absorption in the ileum and catalyzed by
a more restricted number of bacterial species colonizing distal parts of the gut. Whilst the so far best
studied bile acid-dehydroxylating bacterium in the
human gut is Clostridium scindens, species from
mice are either unknown or, if already isolated,
have not been taxonomically described and deposited in reference culture collections. One secondary bile acid-producing species that we have
recently cultured and characterized from the
mouse gut microbiota is Extibacter muris, the
ﬁrst representative of a novel genus which is able
to metabolize the primary bile acids cholic acid
(CA) to deoxycholic acid (DCA) via 7αdehydroxylation.9,10
Considering the inﬂuence of bile acids on metabolic and inﬂammatory responses and the scarcity
of experimental studies using bile acidmetabolizing gut bacteria,11–16 the goal of the present work was to assess the eﬀects of targeted colonization by E. muris in vivo. To that end, germ-free
mice were associated with the minimal bacterial
community Oligo-MM12,17 with or without
E. muris and fed one of two experimental diets
varying in fat content. The main focus was to
study responses in the liver because of its functional
relevance for lipid metabolism.

Results
In vitro metabolism of bile acids

As a foundation for later in vivo experiments, we
aimed to clarify the metabolism of bile acids by the
Oligo-MM12 strains and Extibacter muris in vitro.
First, due to the release of bile acids by the host
in conjugated form, Oligo-MM12 strains were
tested for BSH activity via incubation with either
TDCA or GDCA in both agar- and broth-based
assays. Three Oligo-MM12 strains were consistently
positive across the diﬀerent assays: Bacteroides caecimuris DSM 26085, Biﬁdobacterium animalis DSM
26074, and Enterococcus faecalis DSM 32036
(Figure 1a). Clostridium innocuum DSM 26113
and Flavonifractor plautii DSM 26117 deconjugated TDCA but not GDCA, which tended to inhibit the growth of several strains under the
conditions tested. Muribaculum intestinale DSM
28989 showed inconsistent results depending on
the combination of bile acid tested and assay used:
it was positive for TDCA on agar and GDCA in
broth. Lactobacillus reuteri DSM 32035 was positive
for GDCA deconjugation both on agar and in
broth. The other Oligo-MM12 members either
tested negative for all reactions or their growth
was inhibited by addition of the bile acids
(Acutalibacter muris DSM 26090, Akkermansia
muciniphila DSM 26127, Blautia coccoides DSM
26115, Enterocloster clostridioformis DSM 26114,
Turicimonas muris DSM 26109).
The previously observed ability of E. muris to
produce DCA10 was conﬁrmed, albeit at an amount
approx. 24-fold lower than the positive control
strain C. scindens (0.75 vs. 18 μM, respectively)
(Figure 1b). The fact that the amount of DCA
produced did not mirror the decrease in CA concentrations suggests the formation of intermediates
(e.g. 3, 7, 12-oxo bile acids) not measured by the
quantiﬁcation method used. E. muris did not convert UDCA and CDCA into LCA when provided as
single substrates under the conditions tested
(Figure 1b). When incubated in the presence of
mouse bile (1:300 dilution), E. muris produced up
to 2.2 μM DCA, which was still ca. 6.5-fold lower
than the complex mouse cecal microbiota used as
positive control (Figure 1c). Moreover, E. muris
was not able to catalyze the isomerization of
βMCA into ωMCA.

